ArticleJBMR plus2021

A Prospective Open-Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study.

Salvatore Minisola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.